|
STAT5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.620100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.490400E-02 |
| Normal-vs-Stage2 |
6.013600E-01 |
| Normal-vs-Stage3 |
4.607800E-02 |
| Normal-vs-Stage4 |
8.582000E-03 |
| Stage1-vs-Stage2 |
8.739400E-01 |
| Stage1-vs-Stage3 |
3.164000E-01 |
| Stage1-vs-Stage4 |
1.727600E-01 |
| Stage2-vs-Stage3 |
4.112800E-01 |
| Stage2-vs-Stage4 |
1.433210E-01 |
| Stage3-vs-Stage4 |
4.744000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.971800E-02 |
| Normal-vs-AfricanAmerican |
6.229900E-02 |
| Normal-vs-Asian |
1.496200E-01 |
| Caucasian-vs-AfricanAmerican |
5.247800E-01 |
| Caucasian-vs-Asian |
4.724600E-01 |
| AfricanAmerican-vs-Asian |
5.819200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.273600E-02 |
| Normal-vs-Female |
3.486000E-01 |
| Male-vs-Female |
7.618800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.455630E-02 |
| Normal-vs-Extreme_Weight |
1.071180E-01 |
| Normal-vs-Obese |
4.298400E-01 |
| Normal-vs-Extreme_Obese |
5.018400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.485400E-01 |
| Normal_Weight-vs-Obese |
1.673400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.792800E-01 |
| Extreme_Weight-vs-Obese |
5.313400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.487600E-01 |
| Obese-vs-Extreme_Obese |
7.858200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.316200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.524600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.012500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.060800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.039800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.562100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.898000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.575500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.318640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.903400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.455400E-01 |
| Normal-VS-Type2 PRCC |
4.598300E-04 |
| Normal-VS-KIRP CIMP |
8.223600E-03 |
| Normal-VS-Unclassified PRCC |
8.424000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.955810E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.357500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.049600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.361800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.118200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.287700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.757440E-03 |
| Normal-vs-N1 |
1.783420E-03 |
| Normal-vs-N2 |
4.531600E-01 |
| N0-vs-N1 |
7.349600E-01 |
| N0-vs-N2 |
9.516400E-01 |
| N1-vs-N2 |
8.058800E-01 |
|
|
